RTsafe announces that Elekta is using RTsafe’s PseudoPatient™ technology for End-to-End stereotactic quality assurance (QA) in the new Elekta Assurance solution to deliver safe and efficient brain radiotherapy.

​​​​​​​A research collaboration between RTsafe and Elekta resulted to the world’s first experimental quasi-real-time demonstration of dose accumulation during a clinical IMRT irradiation, a true breakthrough in radiotherapy.

RTsafe announces that it has signed JW Pacific as its exclusive distributor for Hong Kong, Macau, Taiwan & South Korea.